A trial of the effectiveness of vaporised nicotine products for tobacco smoking cessation amongst NSW opiate agonist treatment clients

Hunter New England Area Health Service0 个研究点目标入组 502 人开始时间: 2021年2月12日最近更新: 2024年2月5日

试验速览

暂无简介。

•Inclusion Criteria
•Provide written, informed consent to participate in the study.
•Aged 18 to 65 years
•Be accessing opioid agonist treatment from a participating service
•Current daily tobacco smokers on self-report
•Want to quit or cut down their tobacco smoking
•Be willing and able to comply with requirements of study (including having access to a phone)

•Currently breastfeeding or pregnant, or of childbearing potential and planning/trying to fall pregnant during the study period
•Current, severe medical disorder assessed by study medical officer (such as but not limited to, unstable cardiovascular/peripheral vascular disease, poorly controlled hypertension)
•Current, severe and unstable psychiatric disorder assessed by study medical officer (such as but not limited to, acute psychosis, severe anxiety and/or mood disorder, intent to harm self or others)
•Current enrollment in a clinical trial involving any investigational drug
•Regular use (more than one day per week) of VNP or e-Cigarette containing nicotine in the last 30 days
•Not available for follow-up (e.g. likely imprisonment or transfer out of service to another service that is not a trial recruitment site)

发起方